Cancer
Malignant Uterine Corpus Neoplasm
CI-CAN-00008020Explore in graph →
Top-level411 active trials4 approved drugs28 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00008020Explore in graph →
Clinical trials
1,571 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (168)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02654054 | Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women | completed | Phase 3 | 413 | AbbVieINDUSTRY | 3 | Jun 29, 2020 | clinicaltrials |
| NCT03716414 | Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma | completed | — | 78 | Fudan UniversityOTHER | 1 | Jun 23, 2020 | clinicaltrials |
| NCT02912767 | Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer | completed | — | 625 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 4, 2020 | clinicaltrials |
| NCT01580696 | Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer | completed | Phase 1 / Phase 2 | 51 | COL George Peoples, MD, FACSFED | 1 | May 4, 2020 | clinicaltrials |
| NCT00002807 | Radiation or Observation Only in Endometrial Cancer Who Have Undergone Surgery | completed | N/A | 116 | NCIC Clinical Trials GroupNETWORK | 3 | Apr 6, 2020 | clinicaltrials |
| NCT00004251 | Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer | completed | Phase 2 | 33 | NCIC Clinical Trials GroupNETWORK | 0 | Apr 6, 2020 | clinicaltrials |
| NCT00340262 | Bone Mineral Density and Subsequent Cancer Risk | completed | — | 15,595 | National Cancer Institute (NCI)NIH | 1 | Mar 30, 2020 | clinicaltrials |
| NCT03898947 | Endometrial Changes in Breast Cancer Women With or Without Hormonal Therapies(BETA-1) | completed | — | 1,329 | Università degli Studi dell'InsubriaOTHER | 0 | Mar 25, 2020 | clinicaltrials |
| NCT02834988 | Sentinel Lymph Node Dissection (SLND) in Patients With Apparent Early Stage Endometrial Cancer | completed | — | 76 | University of MiamiOTHER | 1 | Mar 12, 2020 | clinicaltrials |
| NCT04302714 | Hysteroscopic vs. Cervical Injection for Sentinel Node Detection of Endometrial Cancer(SLN_EC) | completed | N/A | 165 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Mar 12, 2020 | clinicaltrials |
| NCT03900104 | Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer | completed | N/A | 81 | Kocaeli UniversityOTHER | 1 | Feb 20, 2020 | clinicaltrials |
| NCT00478426 | Sunitinib Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer | completed | Phase 2 | 34 | National Cancer Institute (NCI)NIH | 2 | Feb 17, 2020 | clinicaltrials |
| NCT01836484 | Diagnostic Accuracy of MRI, DWI MRI, FDG-PET/CT and FEC PET/CT in the Detection of Lymph Node Metastases in Surgically Staged Endometrial and Cervical Carcinoma(MAPPING) | completed | — | 162 | Barts & The London NHS TrustOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT02387645 | LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma(LUDEC) | completed | N/A | 80 | Medical University of ViennaOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT04240730 | Transvaginal Natural Orifice Endoscopic Surgery for Extremely Obese Patients With Early-stage Endometrial Cancer | completed | — | 6 | Dr. Lutfi Kirdar Kartal Training and Research HospitalOTHER_GOV | 1 | Feb 11, 2020 | clinicaltrials |
| NCT02093546 | Biospecimen Collection in Assessing the Effect of Trametinib With or Without Uprosertib on Biomarkers in Patients With Persistent or Recurrent Endometrial Cancer Enrolled on Trial GOG02290 | completed | — | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 28, 2020 | clinicaltrials |
| NCT01870947 | Assisted Exercise in Obese Endometrial Cancer Patients | completed | N/A | 95 | Case Comprehensive Cancer CenterOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT01846520 | Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers | completed | N/A | 200 | City of Hope Medical CenterOTHER | 1 | Jan 23, 2020 | clinicaltrials |
| NCT03540407 | Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma. | completed | Phase 2 | 66 | Catalysis SLINDUSTRY | 1 | Jan 23, 2020 | clinicaltrials |
| NCT03328260 | High Intensity Focused Ultrasound in Uterine Myoma | completed | N/A | 34 | Seoul National University HospitalOTHER | 1 | Jan 3, 2020 | clinicaltrials |
| NCT01237067 | Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers | completed | Phase 1 | 77 | National Cancer Institute (NCI)NIH | 1 | Dec 17, 2019 | clinicaltrials |
| NCT03411980 | Pharmacokinetics and Safety of Vilaprisan in Renal Impairment | completed | Phase 1 | 26 | BayerINDUSTRY | 1 | Dec 3, 2019 | clinicaltrials |
| NCT00205023 | Disseminated Endometrial Cancer Cells During Sonohysterography | completed | N/A | 25 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT00462969 | Cytologic Analysis of Distention Media as a Screening Test for Endometrial Cancer | completed | N/A | 40 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT00543192 | Sexual Functioning in Endometrial Cancer | completed | — | 73 | University of Wisconsin, MadisonOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT02096783 | Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | completed | N/A | 15 | University of Wisconsin, MadisonOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT02470741 | Pilot of Letrozole for Uterine Myomas(PLUM) | completed | Phase 4 | 12 | University of California, San FranciscoOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT01377519 | Magnetic Resonance Guided Focused Ultrasound for Uterine Fibroids(PROMISe) | completed | N/A | 20 | University of California, San FranciscoOTHER | 1 | Nov 5, 2019 | clinicaltrials |
| NCT02115477 | Lymphedema After Primary Surgery for Endometrial Cancer(LASEC) | completed | — | 262 | Preben Kjolhede, MD, professorOTHER | 1 | Oct 25, 2019 | clinicaltrials |
| NCT02844920 | Evaluation of Uterine Patency Following Sonography-guided Transcervical Ablation of Fibroids(OPEN) | completed | — | 37 | GynesonicsINDUSTRY | 4 | Sep 20, 2019 | clinicaltrials |
| NCT04091529 | Tailored Radiofrequency Ablation of Uterine Myomas | completed | N/A | 54 | International Evangelical HospitalOTHER | 1 | Sep 18, 2019 | clinicaltrials |
| NCT02578888 | Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies | completed | N/A | 95 | Albert Einstein College of MedicineOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT02575872 | Physical Activity Behavioral Intervention in Obese Endometrial Cancer Survivors | completed | N/A | 30 | Albert Einstein College of MedicineOTHER | 1 | Sep 16, 2019 | clinicaltrials |
| NCT03427671 | OCL 500 Treatment of Women With Symptomatic Uterine Fibroids | completed | N/A | 12 | IMBiotechnologies Ltd.INDUSTRY | 1 | Sep 12, 2019 | clinicaltrials |
| NCT02068820 | Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG | completed | N/A | 200 | AdventHealthOTHER | 1 | Sep 10, 2019 | clinicaltrials |
| NCT01629563 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLIV) | completed | Phase 3 | 451 | PregLem SAINDUSTRY | 11 | Sep 4, 2019 | clinicaltrials |
| NCT01610375 | Telephone Follow-up After Treatment for Endometrial Cancer(TEACUP) | completed | N/A | 149 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Aug 29, 2019 | clinicaltrials |
| NCT01075386 | The Effects of the Endocrine System on Endometrial Cancer(Ghrelin) | completed | — | 75 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Aug 28, 2019 | clinicaltrials |
| NCT00319748 | Study of Immune Response Modifier in the Treatment of Breast, Ovarian, Endometrial and Cervical Cancers | completed | Phase 2 | 15 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Aug 26, 2019 | clinicaltrials |
| NCT01132820 | Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | Aug 8, 2019 | clinicaltrials |
| NCT01168232 | Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer | completed | Phase 2 | 42 | National Cancer Institute (NCI)NIH | 1 | Aug 8, 2019 | clinicaltrials |
| NCT01220609 | Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Aug 8, 2019 | clinicaltrials |
| NCT01247571 | Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer | completed | Phase 2 | 22 | National Cancer Institute (NCI)NIH | 1 | Aug 8, 2019 | clinicaltrials |
| NCT01266447 | Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer | completed | Phase 2 | 27 | National Cancer Institute (NCI)NIH | 1 | Aug 8, 2019 | clinicaltrials |
| NCT00006089 | Trastuzumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer | completed | Phase 2 | 34 | National Cancer Institute (NCI)NIH | 1 | Jul 31, 2019 | clinicaltrials |
| NCT00339547 | Risk Factors for Uterine Fibroids: A Case Control Study | completed | — | 1,529 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Jul 25, 2019 | clinicaltrials |
| NCT00025506 | Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2019 | clinicaltrials |
| NCT00075400 | Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer | completed | Phase 2 | 26 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2019 | clinicaltrials |
| NCT00095979 | Ixabepilone in Treating Patients With Recurrent or Persistent Endometrial Cancer | completed | Phase 2 | 52 | National Cancer Institute (NCI)NIH | 1 | Jul 24, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Jun 29, 2020source: clinicaltrials